New AI Tool Predicts Risk for Chronic Pain in Cancer Patients

A third of cancer patients face chronic pain - a debilitating condition that can dramatically reduce a person's quality of life, even if their cancer goes into remission.

Although doctors have some tools for addressing chronic pain, figuring out who is most at risk for developing it is no easy feat. But a new study, conducted by researchers at the University of Florida and other institutions, uses artificial intelligence (AI) to predict which breast cancer patients are most at risk for developing chronic pain. The predictive model could help doctors address underlying conditions that contribute to making pain chronic and ultimately lead to more effective treatments.

"We want to understand the factors that lead someone from having cancer to having chronic pain and how can we better manage these factors," said Lisiane Pruinelli, Ph.D., M.S., R.N., FAMIA, the senior author of the new study and a professor of family, community, and health systems science in the UF College of Nursing. "Our goal is to link this information to some profile of patients so we can identify early on what patients are at risk for developing chronic pain."

The findings of the study were published on July 26 in the Journal of Nursing Scholarship. The authors included Pruinelli, Jung In Park, Ph.D., R.N., FAMIA, of the University of California, Irvine, and Steven Johnson, Ph.D., of the University of Minnesota.

The results showed that, when built with detailed data on more than 1,000 breast cancer patients, the AI model could correctly predict which patients would develop chronic pain more than 80% of the time. The leading factors that were associated with chronic pain included anxiety and depression, previous cancer diagnoses, and certain infections.

Implementing a model like this in doctors' offices would require integrating it into the electronic healthcare records systems that are now ubiquitous in clinics, which would take more research. The researchers said the rise of AI has the potential to help doctors tailor their treatments to a patient's unique disease characteristics.

"Now with the amount of data we have, and with the use of artificial intelligence, we can actually personalize treatments based on patient needs and how they would respond to that treatment," Pruinelli said.

The study was based on the large amount of data made available by the All of Us Research Program, a nationwide research campaign from the National Institutes of Health that seeks to collect anonymized healthcare records from 1 million Americans.

"This wouldn't be possible if we didn't have people contributing their data," Pruinelli said.

Park JI, Johnson S, Pruinelli L.
Optimizing pain management in breast cancer care: Utilizing 'All of Us' data and deep learning to identify patients at elevated risk for chronic pain.
J Nurs Scholarsh. 2024 Jul 26. doi: 10.1111/jnu.13009

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...